Jones M P, Pandak W M, Heuman D M, Chiang J Y, Hylemon P B, Vlahcevic Z R
Department of Medicine (Division of Gastroenterology), Medical College of Virginia, Richmond 23298.
J Lipid Res. 1993 Jun;34(6):885-92.
Cholesterol 7 alpha-hydroxylase, the rate-determining enzyme in the bile acid biosynthesis pathway, is regulated in a negative feedback manner by hydrophobic bile salts returning to the liver via the portal circulation. The role of cholesterol in the regulation of cholesterol 7 alpha-hydroxylase and the interrelationship between the cholesterol and bile acid biosynthesis pathways remain controversial. The objective of the present study was to define the role of cholesterol in the regulation of cholesterol 7 alpha-hydroxylase and determine the molecular level of its control. In order to avoid intestinal or intravenous administration of cholesterol, we manipulated the flow of cholesterol within the hepatocytes by decreasing cholesterol synthesis with lovastatin in bile fistula rats (bile acid synthesis is up-regulated), or by increasing cholesterol supply by administering mevalonate, a precursor of cholesterol, to rats with intact enterohepatic circulation (bile acid synthesis is normal). In the first series of studies, lovastatin was administered as a single intravenous bolus (10 mg/kg) to rats with chronic bile fistula and to rats with intact enterohepatic circulation (cholesterol and bile acid synthesis is normal). Three hours after lovastatin administration, cholesterol 7 alpha-hydroxylase specific activity, enzyme mass, mRNA, and gene transcriptional activity were decreased by 35%, 32%, 56%, and 34%, respectively, in rats with chronic bile fistula. In rats with intact enterohepatic circulation, lovastatin administration resulted in a similar decrease (34%) of cholesterol 7 alpha-hydroxylase specific activity.(ABSTRACT TRUNCATED AT 250 WORDS)
胆固醇7α-羟化酶是胆汁酸生物合成途径中的限速酶,通过门静脉循环返回肝脏的疏水性胆盐以负反馈方式对其进行调节。胆固醇在胆固醇7α-羟化酶调节中的作用以及胆固醇与胆汁酸生物合成途径之间的相互关系仍存在争议。本研究的目的是确定胆固醇在胆固醇7α-羟化酶调节中的作用,并确定其调控的分子水平。为了避免肠道或静脉给予胆固醇,我们通过用洛伐他汀降低胆瘘大鼠肝细胞内的胆固醇合成(胆汁酸合成上调),或通过向肠肝循环完整的大鼠给予胆固醇前体甲羟戊酸来增加胆固醇供应(胆汁酸合成正常),从而操纵肝细胞内胆固醇的流动。在第一系列研究中,将洛伐他汀作为单次静脉推注(10mg/kg)给予慢性胆瘘大鼠和肠肝循环完整的大鼠(胆固醇和胆汁酸合成正常)。给予洛伐他汀3小时后,慢性胆瘘大鼠的胆固醇7α-羟化酶比活性、酶量、mRNA和基因转录活性分别降低了35%、32%、56%和34%。在肠肝循环完整的大鼠中,给予洛伐他汀导致胆固醇7α-羟化酶比活性出现类似程度的降低(34%)。(摘要截短于250字)